AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Arizona

SB1752

Mescaline; possession; sale; commercial use

Status

Pending

2026 Session

IntroducedFeb 5, 2026 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Sponsor: Theresa Hatathlie (Democrat)
Type: Decriminalization
Substances: Mescaline

Official text

Summary (from PoliPsy)

Mescaline; possession; sale; commercial use

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: azleg.gov

Legislative history

June 13, 2026
Assigned to House RULES Committee
March 11, 2026
Engrossed (Passed One Chamber)
February 23, 2026
Committee Report
February 18, 2026
Committee Report
February 5, 2026
Introduced

Loading bill…